SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-98-005208
Filing Date
1998-05-15
Accepted
1998-05-15 00:00:00
Documents
6
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 AMENDED FORM S-1 S-1/A 402228
2 FORM OF UNDERWRITING AGREEMENT EX-1 76216
3 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EX-3.1 61083
4 FORM OF OPINION RE LEGALITY EX-5 2215
5 CONSENT OF KPMG PEAT MARWICK EX-23 439
6 CONSENT OF MEDPROBE, INC. EX-23.2 1238
  Complete submission text file 0000950123-98-005208.txt   545419
Mailing Address 103 CARNEGIE CENTER SUITE 102 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 102 103 CARNEGIE CENTER SUITE 102 PRINCETON NJ 08540 6095141060
ANTHRA PHARMACEUTICALS INC (Filer) CIK: 0001054839 (see all company filings)

IRS No.: 223007972 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-47725 | Film No.: 98626382
SIC: 2835 In Vitro & In Vivo Diagnostic Substances